Reach your health milestones with support from Klinic's dedicated team, committed to navigating your path in weight management as Retatrutide's story unfolds
In published clinical trials, the combination's safety profile is described as predominantly gastrointestinal consistent with the profile of both classes (GLP-1 and amylin)
However, these studies are constrained by small sample sizes, short follow-up periods, and limited generalizability across diverse populations
All compounding is from licensed 503A pharmacies, with no insurance required, and HSA/FSA eligibility available
Regular, small protein-rich meals create a more stable digestive environment
If the research timeline permits using the entire vial within 48 hours of thawing, the remaining potency may still be sufficient depending on dose tolerance in your model